![Matthew Korenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Korenberg
Direktor/Vorstandsmitglied bei
PFENEX INC.
Vermögen: 448 294 $ am 31.07.2026
Profil
Matthew Edward Korenberg was the founder of Neurocircuit Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer & Director.
Current jobs include Director at Qualigen, Inc.; Director at The Pelican, Inc. since 2020; Director at Ligand UK Group Ltd. since 2018; Independent Director at Lifecore Biomedical, Inc. since 2024; and Chief Financial Officer, Secretary & Treasurer at Palvella Therapeutics, Inc. since 2024.
Former jobs include Director at Ligand UK Ltd.; Managing Director at Goldman Sachs & Co. LLC.
from 1999 to 2013; Independent Director at AIxCrypto Holdings, Inc. from 2020 to 2024; Director at Ligand UK Research Ltd.; and President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2022 to 2024.
Education includes undergraduate studies at the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 69 967 ( 0,19 % ) | 309 254 $ | 31.07.2026 | |
0,01 % | 12.06.2026 | 1 000 ( 0,01 % ) | 139 040 $ | 31.07.2026 |
Aktive Positionen von Matthew Korenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| PFENEX INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| LIFECORE BIOMEDICAL, INC. | Direktor/Vorstandsmitglied | 01.08.2024 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 12.10.2018 |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Korenberg
| Unternehmen | Position | Ende |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Präsident | 31.10.2024 |
| AIXCRYPTO HOLDINGS, INC. | Direktor/Vorstandsmitglied | 03.10.2024 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | 19.03.2024 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.08.2013 |
| VERNALIS | Direktor/Vorstandsmitglied | - |
Ausbildung von Matthew Korenberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Neurocircuit Therapeutics, Inc. | |
Qualigen Therapeutics, Inc.
 Qualigen Therapeutics, Inc. Packaged SoftwareTechnology Services Develops global ecosystem platform that integrates AI and blockchain systems to connect web apps | Technology Services |
